James Peters, Author at Small Cap Exclusive

Why On4 Communications Inc (OTCMKTS:ONCI) Shares Jumped 85%

On4 Communications Inc (OTCMKTS:ONCI) shares were up 85.71% on Wednesday to $0.00130 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.01. The company has a market cap of $3.64 million at 2.80 billion shares outstanding.

On4 Communications Inc is a company that intends to become the onsite provider of certain mobile home care dental related services to senior citizens in their senior assisted living facilities where such onsite services are not being provided. The company is also focused on providing other medical services, with the additional focus of acquiring and/or merging businesses primarily operating in the healthcare industry. The company was engaged in providing prepackaged software as well.

In a press release, On4 Communications announced that that they have released their fiscal Q1 earnings on OTC Markets and reported their first ever revenues.

“I am proud to announce the first ever revenue flow for On4 Communications which initiated in November 2016 from our initial FMS Clients,” On4 Communications CEO Steve Berman stated. “I also wish to assure our shareholders that we are lowering ONCI’s O/S by 1.5B shares as previously stated and advise our shareholders to please watch for a Supplemental Filing on OTC Markets for the O/S reduction to be reflected soon. As well, we’re currently in the process of redomiciling On4 Communications in the State of Colorado and delivering on our earlier promise of reducing ONCI’s Authorized Shares.”

He added that their reported Q1 revenues only represent the initial FMS purchase orders which began to flow into On4 Communications at the end of November 2016.

ONCI has now entered a bold new era of growth during fiscal Q2 and I very much look forward to renewed communication to market on several exciting growth driving fronts over the next several weeks,” he concluded.

The company’s first project is focusing on businesses operating in the $1.7 trillion U.S. healthcare industry and their new targeted businesses are operating in the trillion-dollar mobile app space. Their first acquisition in this space is FMS Marketing, which is a global creator and distributor of mobile apps for Android and iPhones. The company is also targeting businesses to acquire and joint venture with in the medical marijuana and emerging MJ ancillary products space.

At the start of this year, On4 Communications Inc secured 8 new Auto Dealer Vendors in Florida State for their premium FMS Drive Safe App. Berman noted that it takes approximately 6 months for full vendor implementation but that they extrapolated attaining an average $7K in recurring monthly revenue per vendor.

With the demand for our FMS Drive Safe App service now gaining an incredible amount of traction amongst auto dealers, I will be returning to Florida in approximately 3 weeks to close on 10 more auto dealers who have already expressed a great deal of interest,” Berman explained.

DISCLAIMER: There is a substantial risk of loss with any speculative asset, especially small cap stocks. The opinions expressed are those of the author, and do not constitute recommendations to buy or sell a stock. Do your own research before committing capital.

Amfil Technologies Inc (OTCMKTS:AMFE) Shares To Keep Gaining Ground

Amfil Technologies Inc (OTCMKTS:AMFE) shares advanced 11.83% on Tuesday to $0.0189 and were unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.03. The company has a market cap of $14.52 million at 791.92 million shares outstanding.

Amfil Technologies Inc is a company that operates through its subsidiary, Interloc-Kings Inc, which offers landscape construction and snow removal services in Canada. It also supplies and installs residential and commercial hardscape construction projects, including interlocking stone driveways, walkways, back patio’s, retaining walls and steps, fences, decks and pools, among others during the summer season. Interloc also provides residential winter services in Markham, including winter maintenance services.

The company also owns the rights to Medium Scale Prospecting Mining Permits to over nine sites totaling approximately 10,300 acres in Guyana for exploration of gold. It holds approximately 50% interest in mPact-GROZONE Antimicrobial Systems with distribution rights across the world. The company’s other subsidiaries include Snakes & Lagers Inc. and Snakes & Lattes Inc., which operate board game themed bars and cafes in downtown Toronto, Ontario, Canada.

In a press release, Amfil Technologies Inc shared that the GROzone product line recently received a positive review from Pennsylvania Certified Organic allowing their clients to use it in organic production. Pennsylvania Certified Organics certification program is accredited by the USDA for compliance with the National Organic Program, even as the USDA currently does not recognize it as a crop that can be organically grown or called certified organic just yet.

Still, being allowed to use this product line for any and all forms of what is currently deemed agricultural production is reassuring as marijuana cultivators that want to follow organic practices essentially follow the National Organic Program guidelines. Alternate certifications are currently being developed for the industry.

Also, achieving this certified status allows producers such as Amfil Technologies Inc to charge a premium for “Clean” or “Organic” products. Aside from that, it helps ensure that the producer or manufacturer will never have product recall or product failure due to any elevated levels of harmful ingredients used throughout the grow process that can make them susceptible to liability from the consumer. After all, some reports have revealed that residual pesticide in marijuana led to product recalls and lawsuits recently.

Originally developed in 2014, GROzone is a triple-function sanitization unit capable of naturally eliminating 99.9% of water and airborne pathogens. A unit can also regulate a given facility’s water supply, oxygenating the water and maintaining a consistent PPM infusion of ozone that prevents the formation of algae, bacteria or mold, eliminating the need for pesticides or carcinogenic products.

1PM Industries Inc (OTCMKTS:OPMZ) Investors Cheer New Business Model

1PM Industries Inc (OTCMKTS:OPMZ) shares were up 12% on Wednesday to $0.00280 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.38. The company has a market cap of $551K at 165.50 million shares outstanding.

Formerly known as Torrent Energy Corp, 1PM Industries Inc is a company that is focused on the sale and distribution of medical marijuana under the brand Von Baron Farms. It sells various products, including Cookie Spread, Peanut Butter, CBD Cookie Spread, CBD Mango Shot, THC Shot, Combo Shot, and Pancake and Waffle Batter. The Company distributes its Von Baron Farms product at www.vonbaronfarms.com. The company sells its products in approximately 40 dispensaries.

1PM Industries Inc is also in the process of selling its Von Baron Farms product line in non-medical marijuana product line through Amazon and eBay. It is also engaged in the development of a CBD product line. The company developed a line health and wellness products under the NewGenica brand, under which it developed four products including AquaTrim, DreamTrim, Eat & Trim and D-Tox 15. The company purchases the products from a third-party manufacturer who private labels health and wellness products.

In a press release, 1PM Industries Inc announced that it has transitioned into a new business model in the best interest of the company and the shareholders.

For years the management team of 1pm Industries has done one thing in particular very successfully and that’s helping private companies achieve publicly traded status. There is significant revenue generated from the process of taking a company public with multiple revenue streams being generated from each account,” said CEO Joseph Wades. “Had we remained on our former business trajectory, it would have taken all year or more to generate the revenue that we recently generated from just one client. Instead of continuing our efforts as a private endeavor, we have decided to roll all of our activities related to helping private companies achieve publicly traded status into 1PM Industries Inc and that will become our primary focus for the long term.”

Wades went on to say that he wants shareholders to know that this is an extremely positive move for the company as they have 18 years of experience helping companies to go public and generated $1.3 million on just one client contract, based on their latest 8K filing. With that, he expressed confidence about reaching revenue of $4 million this year up to $6 million.

I would like to reassure everyone that under no circumstances will we initiate a reverse split for any reason in the foreseeable future. What would be more likely to occur at this point would be a reduction in the authorized shares and that is currently under consideration. Also, as of today, for clarification, we currently have 244,948,828 shares outstanding with 137,246,677 shares in the float. We look forward to providing more information on our current business activities in the next few weeks and as always, we thank you for your support,” he concluded.

Why Halitron (OTCMKTS:HAON) Shares Jumped 30%

Halitron (OTCMKTS:HAON) shares were up 31.58% to $0.00250 on Monday and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.01. The company has a market cap of $903K at 418.43 million shares outstanding.

Halitron is an equity investment holding company that is focused on implementing an acquisition roll-up model of acquiring high growth sales and marketing businesses. The company is structured with two Strategic Business Units: Sales & Marketing Division and a Manufacturing Division. It is focused on acquisition targets that provide sales, marketing, and manufacturing services and products.

Its portfolio holding include CinchSigns, NDG Holdings, Inc., Teknik Digital Arts, Inc. and Archival Museum Supplies. The company has two footprints; one in Newtown, Connecticut, that houses sales, marketing, finance, and second location in San Diego, California, which is the distribution point for products, which are primarily made in and around Tijuana, Mexico. The company is also focused on acquiring bankrupt, distressed or insolvent companies where it can acquire the business inexpensively and then roll the assets into its infrastructure.

In a press release this week, Halitron announced that the company closed on the $300,000.00 in financing needed to boost revenue of its four existing legacy brands to between $3-5 million annually. This is in the form of a non-toxic one year credit facility whereby the company may draw down minimum increments of $5,000, up to a total of $300,000, which carries an annual interest rate of 8%. This means that the debt thereunder is not convertible into equity at a discount to prevailing market prices.

Today we are drawing down our first tranche of capital and are excited to implement our strategic plan,” cited Bernard Findley, Halitron CEO.

The company recently engaged Freidman LLP to perform an audit of Halitron in preparation for listing on the OTCQB market. This is expected to be completed by the end of the month, followed by the filing of an annual report with the SEC to be listed on the OTCQB as a fully reporting company by mid-year 2017.

Lastly, Halitron shared that it is in the final stages of a spin out and merger transaction that has been in the works for the past three months. To be specific, two of its brands are in the process of being spun out into an online social marketing or digital storage company, which is currently a public company. With this, shareholders are expected to receive a stock dividend of 40 shares of the new company’s common stock for every 1,000 shares of Halitron common stock owned, subject to review and approval by FINRA.

What Management Restructuring Means for iSIGN Media Solutions Inc (OTCMKTS:ISDSF) Shares

iSIGN Media Solutions Inc (OTCMKTS:ISDSF) shares were flat on Wednesday at $0.0898 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.06 to $0.13. The company has a market cap of $9.76 million at 108.39 million shares outstanding.

iSIGN Media Solutions Inc is a data-focused, software-as-a-service (SaaS) company that is a pioneering leader in gathering point-of-sale data and mobile shopper preferences to generate actionable data and reveal valuable consumer insights. Creators of the Smart suite of products, a patented interactive proximity marketing technology, the company enables brands to deliver targeted messaging, personalized offers and loyalty perks to consumers’ mobile devices in proximity and with real-time proof of redemption.

Its data gathering capabilities provide analytics on price points, typical purchases, in-store dwell time and other shopper metrics that identify emerging consumer behaviors. These insights enable smarter business decisions and provide increased ROI metrics for more transparent marketing. iSIGN delivers relevant, timely messages on an opt-in basis at no charge to consumers, transmitting rich media to consumer mobile devices via Bluetooth and WiFi connectivity in complete privacy as opposed to iBeacons, apps, downloads and required surrendering of personal information. Proven to increase brand engagement and customer loyalty, the company generates preference-based, predictive “clean data” without compromising consumer privacy.

In a press release this week, iSIGN Media Solutions Inc shared that it will be having restructuring of its senior management. Effective March 1, 2017, Joe Kozar, a major shareholder in the company, will be taking on the role of Interim Chief Executive Officer while Alex Romanov, the company’s former Chief Executive Officer, will be undertaking the role of Vice President, Sales and Operations and will retain his Board position.

This change is being implement by the Board in order to allow Alex to fully concentrate upon sales and revenues,” stated Mr. Joe Kozar, iSIGN Media Solutions Inc’s Interim Chief Executive Officer. “With the recent sales of Smart Antennas to our resellers, We Build Apps, LLC and Rich Multimedia Technologies, Inc, it was mutually agreed that iSIGN would best be served by having Alex concentrate his efforts on the sales function.”

These appointments are for an interim period of six months, at which time the Board may elect to extend either of these appointments or appoint new executives to these roles.

I look forward to working with Joe and will support him fully as he undertakes the Chief Executive Officer role and challenges at this pivotal time in iSIGN,” stated Mr. Alex Romanov, iSIGN’s Vice President, Sales and Operations.

Aside from that iSIGN Media Solutions Inc announced that Mr. Prakash Shukla has resigned from the Company’s Board of Directors, effective January 23, 2017 due to an increased work-related schedule, with extensive travel outside of North America.

Why Castle Brands Inc (NYSEMKT:ROX) Shares Jumped 42%

Castle Brands Inc (NYSEMKT:ROX) shares were up 42.49% on Tuesday to $1.04 and unchanged in after-hours trading. Share prices have been trading in a 52-week range of $0.65 to $1.45. The company has a market cap of $161.44 million at 160.97 million shares outstanding.

Castle Brands Inc is a company that develops and markets premium and super premium brands in the beverage alcohol categories. It is engaged in the sale of premium beverage alcohol. Its beverage alcohol categories include rum, whiskey, liqueurs, vodka and tequila. It has operations in two geographic areas: International and the United States. The company distributes its products in all 50 states of the United States and the District of Columbia.

Its brands include Gosling’s rum, Gosling’s Stormy Ginger Beer, Gosling’s Dark ‘n Stormy ready-to-drink cocktail, Jefferson’s bourbon, Jefferson’s Reserve, Jefferson’s Ocean Aged at Sea, Jefferson’s Wine Finish Collection, Jefferson’s The Manhattan: Barrel Finished Cocktail, Jefferson’s Chef’s Collaboration, Jefferson’s Wood Experiment, Jefferson’s Presidential Select, Jefferson’s Rye whiskey, Pallini liqueurs, Clontarf Irish whiskey, Knappogue Castle Whiskey, Brady’s Irish Cream, Boru vodka, Tierras tequila, Celtic Honey liqueur and Gozio amaretto.

In a press release, Castle Brands Inc shared that they reached an agreement to supply Goslings Stormy Ginger Beer and Goslings Stormy Diet Ginger Beer to all U.S. Walmart stores by this month.

Supplying Walmart with both the Regular and Diet Goslings Stormy Ginger Beer adds to the brand’s impressive growth and strengthens our position in the U.S. market. We are pleased that Walmart has implemented a full store roll-out. We look forward to working with Walmart to promote the continued success of Goslings Stormy Ginger Beer,” remarked John Glover, Chief Operating Officer of Castle Brands Inc.

Prior to this, several investment companies issued “buy” ratings on Castle Brands Inc shares while Director Richard Krasno recently acquired 30,000 shares of the company’s stock in a transaction on Tuesday, December 27th at $0.72 per share.

The agreement with Walmart, the world’s largest retailer, to supply approximately 4,500 stores with Goslings Stormy Ginger Beer, which we believe is the largest selling U.S. premium ginger beer, is an indication of the strength and growing value of the Goslings brand,” said Malcolm Gosling, President of Goslings-Castle Partners Inc.

Expectations of seeing the other brands that Castle Brands Inc carries on the Walmart shelves are buoying the company’s stock higher, although the recent arrangement could mean a strong influx of revenues this month and in the coming quarters.

Price gapped significantly higher upon seeing the announcement yesterday and is currently nearing record highs. Investor interest could continue to pick up in the coming days as the agreement bears fruit, possibly sustaining the strong bullish momentum for Castle Brands Inc stock.

Note, however, that the company’s latest earnings report showed breakeven figures even as revenues fell short of estimates. Whiskey revenues increased 14.5% from the year-ago quarter while Goslings Stormy Ginger Beer case sales increased 42.9% to approximately 339,000 cases. The company’s quarterly revenues of $18.31 million fell short of estimates at $20.74 million. Still, revenues reflected a 6.4% year-over-year rise on U.S. sales growth of Jefferson’s bourbons, the Irish whiskies and Goslings Stormy Ginger Beer.

Advaxis Inc (NASDAQ:ADXS) Enters Licensing Agreement with SELLAS

Advaxis Inc (NASDAQ:ADXS) shares rose 6.74% on Monday to $9.03 and an additional 1.88% to $9.20 in after-hours trading. Share prices have been trading in a 52-week range of $5.45 to $16.30. The company has a market cap of $357.65 million at 40.12 million shares outstanding.

Advaxis Inc is a clinical-stage biotechnology company that is focused on the discovery, development and commercialization of Listeria monocytogenes (Lm)-Listeriolysin O (LLO) cancer immunotherapies. These immunotherapies are based on a platform technology that utilizes live attenuated Lm bioengineered to secrete antigen/adjuvant fusion proteins.

These Lm-LLO strains integrate multiple functions into a single immunotherapy as they access and direct antigen presenting cells to stimulate anti-tumor T-cell immunity, stimulate and activate the immune system with the equivalent of multiple adjuvants, and simultaneously reduce tumor protection in the tumor microenvironment to enable the T-cells to eliminate tumors. Axalimogene filolisbac is its lead Lm-LLO immunotherapy product candidate for the treatment of Human Papilloma Virus-associated cancers. ADXS-PSA is its Lm-LLO immunotherapy product candidate that targets the Prostate Specific Antigen (PSA) associated with prostate cancer.

In a press release, Advaxis Inc shared that it granted SELLAS a license to develop a novel cancer immunotherapy agent using Advaxis’ proprietary Lm-based antigen delivery technology with SELLAS’ patented WT1 targeted heteroclitic peptide antigen mixture. This combination has the potential to precisely direct an immune response, yielding improved clinical activity against many cancer types that express WT1. SELLAS’ future clinical studies will investigate this capability in the presence of measurable residual or recurrent disease.

WT1 is one of the most widely expressed cancer antigens and was named a top target for cancer immunotherapy by the National Cancer Institute,” said Daniel J. O’Connor, President and Chief Executive Officer of Advaxis Inc. “SELLAS’ proprietary galinpepimut-S therapy has already demonstrated clinical benefit and a strong immune response against WT1 expressing cancer cells. We believe that the use of our proprietary Lm-based antigen delivery technology with SELLAS’ proprietary technology could result in a very compelling WT1-targeted cancer immunotherapy.”

Under this agreement, Advaxis Inc will conduct all pre-clinical activities required for an IND filing then SELLAS will be responsible for all clinical development and commercial activities. Advaxis Inc will receive future payments of up to $358 million from SELLAS if certain development, regulatory, and commercial milestones are met.

The combined Advaxis-SELLAS Lm-WT1 active immunotherapy candidate has the potential to deliver SELLAS’ WT1 proprietary peptide antigens in a novel way, taking advantage of our antigen’s ability to target a wide variety of tumors of diverse immune system HLA genotypes. The delivery afforded by the Advaxis technology expands upon our current programs and should substantially enhance the clinical utility seen with galinpepimut-S, and eventually, the cancer immunotherapy armamentarium for a variety of tumors,” added Angelos Stergiou, MD, ScD h.c., Vice Chairman and Chief Executive Officer of SELLAS.

Advantis Corporation (OTCMKTS:ADVT) Rolls Out Cannabis Products for Pain Relief

Advantis Corporation (OTCMKTS:ADVT) shares rose 13.56% to $0.0335 and were flat in after-hours trading. Share prices have been trading in a 52-week range of $0.00 to $0.03. The company has a market cap of $13.96 million at 465.48 million shares outstanding.

Advantis Corporation is a company that is focused on helping people take control of their health and pain management needs. It does this through partnerships innovative companies in the nutraceutical and alternative health care industries, making the company uniquely positioned to provide the guidance and support to assist in delivering products and services that address the needs of these individuals. Their strategy involves acquiring ownership in developing companies and providing consultation to improve product lines, expand distribution channels, and heighten brand value. Advantis concentrates on healthcare and pain management sectors that forecast staggering growth, identifying partners that possess the potential to capitalize on this trend.

In a press release yesterday, Advantis Corporation announced that it begins distribution of topical cannabis roll-on and Tinctures to treat pain conditions. In particular, Elixicure is a line of CBD dominant products used to treat pain without the psychoactive effects associated with THC. Its pain relief roll-onis specially formulated, using the extract of the cannabis plant, which contains the principal cannabinoid CBD while the pain cream includes over 90% Certified Organic ingredients and is specially formulated with Counter-Irritants to block pain receptors and Salicylic Acids to provide a deep penetrating Aspirin-like relief.

Elixicure utilizes the purest, pharmaceutically derived essential oils and active ingredients to create products that are superior in quality than those available in the marketplace today, and we are very excited to add them to our rapidly growing portfolio of products,” said Advantis Corporation CEO Christopher Swartz in a recent press conference.

The company has been on an all-out media blitz to provide exposure to deliver attention to their progress and product lines. They have also tapped UFC Legend Kimo Leopoldo as a brand ambassador since many high-profile fighters have been lobbying to make CBD remedies legal.

My passion for fighting has been a painful one. The day-to-day grind in the gym as well as the battles in The Octagon left me with aches and pains. The doctors prescribe medicines that may help with this pain, but the side effects from those medicines outweigh the benefits. The Elixicure line of products have relieved my pain with zero side effects,” said Kimo.

In a previous announcement CEO Swartz hinted that “revenue is about to explode” as the company has several efforts lined up for 2017. He added that the company is poised to reach its highest revenue ever for the year and that this momentum can be sustained in the foreseeable future.

We have seen the problem with chronic pain conditions increase exponentially and with that, opiate misuse and addiction as well. I have personally seen all this happen and have observed (too many times) people whom have lost hope,” Swartz further explained, “I have been passionate about creating solutions to effectively treat the masses without the negative side effects associated with opioids. Elixcure is the answer, and we are excited beyond belief to share this remedy with everyone in need.”

Author: James Peters